Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Robotic Use Increases to Speed Lab Workflow

By LabMedica International staff writers
Posted on 28 Jun 2017
Robotic lab automation is making progress and removing some of the labor in laboratories, but rarely is it replacing all functions. More...
Although the most common use of robots is partial, the number of laboratories using them is on the rise. Without robotics and other types of automation, laboratories may be unable to keep pace with testing, the complexities of new tests, such as those involving molecular diagnostics, and the loss of experienced technicians and technologists. These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

Currently, robotics are finding use in several laboratory processes, ranging from the capping and decapping of sample bottles to high throughput screening. However, one of the major constraints to market growth is the limited adoption of automation and robotics – 10% or less of automation – by small and medium-sized laboratories – those laboratories that process fewer than 100 tubes on a daily basis.

Going forward, much emphasis will be placed on modular robotic automation, which is extremely important for laboratories looking to speed their workflow to keep up with the increasing number of tests, including molecular tests. In order to establish themselves in the market place, robotic systems vendors need to increase productivity and efficiency at laboratories while also helping them to cut costs and errors, and improve productivity. To achieve this, robotics must prove itself as a solution that can address and optimize workflow and many of the phases involved in clinical diagnostics, such as sample collection and sample processing.

“Total lab automation may be appropriate for large-size laboratories, it is not suited for smaller laboratories. It can lead to an increase in the total cost of automation. Moreover, it gives many laboratories little option for future planning, especially if it turns out they do not need to have extensively automated,” said Joe Constance, the author of the study. “Investing in laboratory automation systems is an expensive proposition, and may not be affordable to small and medium-sized laboratories, even if it is a one-time investment.”

Related Links:
Kalorama Information


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.